SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Livent Corporation (LTHM) trades at a trailing P/E of 12.1. Trailing earnings yield is 8.24%.
Criteria proven by this page:
- VALUE (93/100, Pass) — P/E is below market average (12.1); analyst target implies upside (+65.5%); earnings yield beats bond yields (8.24%).
- Trailing Earnings Yield 8.24% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.
- Analyst consensus target $27.33 (+65.5% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 79/100 with 3/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
93/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — LTHM
Valuation Multiples
P/E (TTM)12.1
Forward P/EN/A
PEG Ratio0.00
Forward PEGN/A
P/B Ratio0.00
P/S Ratio4.09
EV/EBITDA0.0
Per Share Data
EPS (TTM)$1.36
Book Value / Share$0.00
Revenue / Share$4.03
FCF / Share$0.00
Yields & Fair Value
Earnings Yield8.24%
Dividend Yield0.00%
Analyst Target$27.33 (+65.5%)
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$0.33 |
$264.1M |
$47.1M |
17.8% |
| 2017 |
$0.29 |
$347.4M |
$42.2M |
12.1% |
| 2018 |
$0.99 |
$442.5M |
$126.1M |
28.5% |
| 2019 |
$0.34 |
$388.4M |
$50.2M |
12.9% |
| 2020 |
$-0.13 |
$288.2M |
$-18.9M |
-6.6% |
| 2021 |
$0.00 |
$420.4M |
$600K |
0.1% |
| 2022 |
$1.36 |
$813.2M |
$273.5M |
33.6% |
